Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells

Carcinogenesis

Volumn 18, Issue 11, 1997, Pages 2063-2069

  Mu, Zhao Mei ^a   Le, Xiao Feng ^a   Vallian, Sadeq ^a   Glassman, Armand B ^a   Chang, Kun Sang ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; PHOSPHOPROTEIN; RETINOBLASTOMA PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CONTROLLED STUDY; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

CDC2-CDC28 KINASES; CELL CYCLE; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; GENE EXPRESSION; HELA CELLS; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0031418659     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.11.2063     Document Type: Article

References (33)

1. Borrow, J., Goddard, A.D., Sheer, D. and Solomon, E. (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science, 249, 1577-1580.
2. de The, H., Chomienne, C., Lanotte, M., Degos, L. and Dejean, A. (1990) The t(15;17) translocation of acute promyelocytic leukemia fuses retinoic acid receptor α gene to a novel transcribed locus. Nature, 347, 558-561.
3. Longo, L. et al. (1990) Rearrangements and aberrant expression of the retinoic acid receptor a gene in acute promyelocytic leukemia. J. Exp. Med., 172, 1571-1575.
4. Chang, K.S., Stass, S.A., Chu, D.T., Deaven, L.L., Trujillo, J.M. and Freireich, E.J. (1992) Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol. Cell. Biol., 12, 800-810.
5. de The, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. and Dejean, A. (1991) The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 66, 675-684.
6. Goddard, A., Borrow, J., Freemont, P.S. and Solomon. (1991) Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science, 254, 1371-1374.
7. Kakizuka, A., Miller, W.H., Umesono, K., Warrell, R.P., Frankel, S.R., Murty, V.V.V.S., Dmitrovsky, E. and Evans, R.M. (1991) Chromosomal translocation t(15;17) in human acute leukemia fuses RARα with novel putative transcription factor, PML. Cell, 66, 663-674.
8. Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M.P., Durand, B., Lanotte, M., Berger, R. and Chambon, P. (1992) Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J., 11, 629-642.
9. Pandolfi, P.P., Grignani, F., Alcalay, M., Mencarelli, A., Biondi, A., LoCoco, F., Grignani, F. and Pelicci, P.G. (1991) Structure and origin of the acute promyelocytic leukemia myl/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogenesis, 6, 1285-1292.
10. Grignani, F. et al. (1993) The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell, 74, 423-431.
11. Robertson, K.A., Emami, B., Mueller, L. and Collins, S.J. (1992) Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells. Mol. Cell. Biol., 12, 3743-3749.
12. Dyck, J.A., Maul, G.G., Miller, W.H., Chen, J.D., Kakizuka, A. and Evans, R.M. (1994) A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell, 76, 333-343.
13. Weis, K., Ramboud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. and Dejean, A. (1994) Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell, 76, 345-356.
14. Koken, M.H.M. et al. (1994) The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J., 13, 1073-1083.
15. Mu, Z.M., Chin, K.V., Liu, J.H., Lozano, G. and Chang, K.S. (1994) PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol., 14, 6858-6867.
16. Guiochon-Mantel, A., Savouret, J.F., Quignon, F., Delabre, K., Milgrom, E. and de The, H. (1995) Effect of PML and PML-RARα on the transactivation properties and subcellular distribution of steroid hormone receptors. Mol. Endocrinol., 9, 1791-1803.
17. Freemont, P.S., Hanson, I.M. and Trowsdale, J. (1991) A novel cycteine-rich sequence motif. Cell, 64, 483-484.
18. Reddy, B.A., Etkin, L.D. and Freemont, P.S. (1992) A novel zinc finger coiled-coil domain in a family of nuclear protein. Trends Biochem. Sci., 17, 344-345.
19. Borden, K.L.B., Boddy, M.N., Lally, J., O'Reilly, N.J. and Freemont, P.S. (1995) The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J., 14, 461-472.
20. Chang, K.S., Fan, Y.H., Andreeff, M., Liu, J. and Mu, Z.M. (1995) The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood, 85, 3646-3653.
21. Ascoli, C.A. and Maul, G.G. (1991) Identification of a novel nuclear domain. J. Cell Biol., 112, 785-795.
22. Xie, K., Lambie, E.J. and Snyder, M. (1993) Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell. Biol., 13, 6170-6179.
23. Koken, M.H.N. et al. (1995) The PML growth suppressor has an altered expression in human oncogenesis. Oncogene, 10, 1315-1324.
24. Liu, J.H., Mu, Z.M. and Chang, K.S. (1995) PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J. Exp. Med., 181, 1965-1973.
25. Terris, B., Baldin, V., Dubois, S., Degatt, C., Flejou, J.F., Henin, D. and Dejean, A. (1995) PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res., 55, 1590-1597.
26. Gleave, M.E., Hsieh, J.T., Gao, C., Von Eschenbach, A.C. and Chung, LW.K. (1991) Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res., 51, 3753-3761.
27. Mesnil, M., Krutovskikh, V., Piccoli, C., Elfgang, C., Traub, O., Willecke, K. and Yamasaki, H. (1995) Negative growth control of HeLa cells by connexin genes: connexin species specificity. Cancer Res., 55, 629-639.
28. Hirama, T. and Koeffler, H.P. (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86, 841-854.
29. Kuerbitz, S.J., Plunkett, B.S., Walsh, W.V. and Kastan, M.B. (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl Acad. Sci. USA, 89, 7491-7495.
30. Harper, J.W. et al. (1995) Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 6, 387-400.
31. INK4/MTS2-related CDK6 inhibitor, correlates with wild type pRb function. Genes Dev., 8, 2939-2952.
32. Ewen, M.E. (1994) The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev., 13, 45-66.
33. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.